Trifluridine/tipiracil versus placebo in patients with ...
Methods: TAGS was a randomised, double-blind, placebo-controlled, phase 3 trial done in 110 academic hospitals in 17 countries. Patients aged 18 years or older with histologically confirmed, non-resectable, metastatic gastric adenocarcinoma (including adenocarcinoma of the gastroesophageal junction) as defined by the American Joint Committee on ...https://pubmed.ncbi.nlm.nih.gov/30355453 Trifluridinetipiracilversusplaceboinpatientswith